Formulation and evaluation of novel mucoadhesive drug delivery systems against oral buccal infectious disease
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
newline The active compound against Candida albicans, Porphyromonas gingivalis,
newlineFusobacterium nucleatum, Prevotella intermedia, Provetella oralis, and Prevotella buccae
newlinewas isolated from the plant Mollugo pentaphylla Linn. The isolate was identified as
newlinestigmasterol based on FTIR, DSC, NMR and Mass spectral analysis. The isolated
newlinestigmasterol reproduced paramount antifungal activity against Candida albicans at 100
newlineµg/mL concentration. The in-vivo study revealed that the viable fungal cell count of the
newlineCandida albicans infected tongue homogenates decreased significantly after 21 days of
newlinetreatment with isolated stigmasterol and histopathological study also narrated the recovery
newlineof papillae, reorganization of basal cell layer and newly formed papillae after 21 to 28
newlinedays treatment.
newlineThe plant isolate was encapsulated in glutaraldehyde cross linked chitosan
newlinemicrospheres. The compatibility study of isolated compound with chitosan was performed
newlineby FTIR and DSC study. The fabricated plant isolate encapsulated microspheres in
newlinevarying concentration of chitosan and span 80 were characterized for surface morphology,
newlineloading efficacy and entrapment efficacy in order to optimize the best encapsulated isolate
newlinein microspheres. The optimized microspheres were taken for crystallinity study by XRD
newlineand DSC in the interest of determination of the % crystallinity of the isolate encapsulated
newlinein fabricated optimized microspheres. The activation energy of permeation, partition and
newlinediffusion of stigmasterol from the optimized microspheres were valued to comprehend the
newlinepermeation kinetic in increasing temperature. At the site of application, the formulation
newlinerepresenting minimum activation energy exhibited the elevated stigmasterol permeation
newlinethreshold. The effectiveness of the encapsulation and the capacity of the mucoadhesive
newlinewas assumed to be proportional to the polymer-emulsifier proportion. The in-vitro release
newlineanalysis narrated the direction of release of stigmasterol from formulated crafted
newlinemicrospheres to be anomalous or non-fickian, which is the consequence of both diffusion
newlineand erosion regulated release. The in-vivo study showed significant anti-oral candidiasis
newlineaction during 21-28 days of treatment.
newline